Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Vaccines (Conference News)
Allogeneic Vaccines May Be Viable Alternative to Autologous Vaccines
November 24th, 1997
Success in animal models suggests that allogeneic cell cancer vaccines may be an effective alternative to autologous cell cancer vaccines. The use of autologous cell cancer vaccines in clinical practice is limited by the invasive nature of harvesting cells, as well as the difficulty and expense of culturing and processing these cells. Justina Kayaga, representing colleagues from the St. George's Hospital Medical School, the Kings College School of Medicine and Dentistry, and the Royal Marsden Hospital, United Kingdom, presented results from animal studies using an alternative allogenic melanoma cell vaccine at the 3rd European Conference on Gene Therapy of Cancer, held...
Source: Cancer Weekly (1997-11-24)
|
